Skip to content

Clinical trials

Withdrawn Phase 1 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Status: Withdrawn Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20072
20081
20092
20101
20111
20121
20142
20161
20171
20181
20191
20211
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Roswell Park Cancer Institute2
Amgen1
Barbara Ann Karmanos Cancer Institute1
Beijing Kejing Biotechnology Co., Ltd.1
Benjamin Movsas, M.D.1
Cancer Trials Ireland1
Dartmouth-Hitchcock Medical Center1
Eckhard Podack1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms27
Carcinoma, Non-Small-Cell Lung14
Breast Neoplasms7
Neoplasms4
Ovarian Neoplasms3
Pancreatic Neoplasms2
Prostatic Neoplasms2
Small Cell Lung Carcinoma2
Stomach Neoplasms2
Adenocarcinoma1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.